Your browser doesn't support javascript.
loading
The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma-A Retrospective, Real-World Cohort Study.
Haist, Maximilian; Stege, Henner; Ebner, Ronja; Fleischer, Maria Isabel; Loquai, Carmen; Grabbe, Stephan.
Afiliación
  • Haist M; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
  • Stege H; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
  • Ebner R; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
  • Fleischer MI; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
  • Loquai C; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
  • Grabbe S; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
Cancers (Basel) ; 14(9)2022 Apr 21.
Article en En | MEDLINE | ID: mdl-35565212
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Alemania